Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
Sixth International Conference on Alzheimer’s Disease and Related Disorders: Selected Abstracts

The Interaction Between Vascular Factors and Alzheimer's Disease

I. Skoog

Göteborg University, Institute of Clinical Neuroscience, Department of Psychiatry, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden

Alzheimer's disease is a primary degenerative dementia, characterised by degeneration of specific nerve cells and the accumulation of the b-amyloid peptide in the brain, and is not considered to be of vascular origin. Indeed, stroke and severe cardiovascular diseases are generally exclusionary for the clinical diagnosis. However, during recent years both epidemiological and neuropathological studies have suggested an association between Alzheimer's disease and several vascular risk factors, such as hypertension, non-dipping blood pressure pattern, coronary heart disease, atrial fibrillation, diabetes mellitus, ischaemic white matter lesions and generalised atherosclerosis.

Although these findings may reflect an overdiagnosis of Alzheimer's disease in individuals with silent cerebrovascular disease, there are also alternative explanations. Lesions in the cerebral microcirculation with an increased vascular permeability are often reported in Alzheimer's disease. A blood-brain barrier dysfunction may therefore be involved in the aetiology and pathogenesis of Alzheimer's disease. This may increase the possibility that substances from serum reach the brain, where they may interact with neurons. Alzheimer's disease may also lead to lesions in the cerebral microvasculature, as b-amyloid interacting with endothelial cells produces superoxide radicals, which causes endothelial damage. Other factors that may be involved in the pathogenesis both of vascular disorders and Alzheimer's disease are disturbances in the renin-angiotensin system, inheritance of the apolipoprotein E e4 allele, oxidative stress with the formation of free radicals, apoptosis, and psychological stress.

In summary, the mechanism behind the association between Alzheimer's disease and vascular disorders is not clear. Possible reasons include overdiagnosis of Alzheimer's disease in cases of vascular dementia, that cerebrovascular disease may affects the clinical expression of Alzheimer's disease or stimulate the Alzheimer's disease process, that similar mechanisms may be involved in the pathogenesis of both disorders, and that Alzheimer's disease may increase the risk of vascular disease.

Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad